100 related articles for article (PubMed ID: 20645431)
1. Screening coagulation testing using the APTT: which reagent to choose?
Dembitzer FR; Suarez Y; Aledort LM; Peerschke EI
Am J Hematol; 2010 Sep; 85(9):726. PubMed ID: 20645431
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization.
Fritsma GA; Dembitzer FR; Randhawa A; Marques MB; Van Cott EM; Adcock-Funk D; Peerschke EI
Am J Clin Pathol; 2012 Jun; 137(6):904-8. PubMed ID: 22586049
[TBL] [Abstract][Full Text] [Related]
3. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
[TBL] [Abstract][Full Text] [Related]
4. [Cross-mixing test to detect lupus anticoagulant for diagnosis of antiphospholipid syndrome].
Ieko M; Naito S; Yoshida M
Rinsho Byori; 2009 Oct; 57(10):990-8. PubMed ID: 19928497
[TBL] [Abstract][Full Text] [Related]
5. Activated partial thromboplastin time reagent sensitivity to the presence of the lupus anticoagulant.
Adcock DM; Marlar RA
Arch Pathol Lab Med; 1992 Aug; 116(8):837-40. PubMed ID: 1497465
[TBL] [Abstract][Full Text] [Related]
6. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
Favaloro EJ; Kershaw G; Mohammed S; Lippi G
Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
[TBL] [Abstract][Full Text] [Related]
7. Two different incubation times for the activated partial thromboplastin time (APTT): a new criterion for diagnosis of lupus anticoagulant.
Robert A
Thromb Haemost; 1994 Feb; 71(2):220-4. PubMed ID: 8191402
[TBL] [Abstract][Full Text] [Related]
8. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
Arnout J; Meijer P; Vermylen J
Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
[TBL] [Abstract][Full Text] [Related]
9. Interference from lupus anticoagulant on von Willebrand factor measurement in splenic marginal zone lymphoma: a case report.
Vinholt PJ; Nybo M
Blood Coagul Fibrinolysis; 2015 Jun; 26(4):454-7. PubMed ID: 25485787
[TBL] [Abstract][Full Text] [Related]
10. Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices.
Moffat KA; Ledford-Kraemer MR; Plumhoff EA; McKay H; Nichols WL; Meijer P; Hayward CP
Thromb Haemost; 2009 Jan; 101(1):178-84. PubMed ID: 19132206
[TBL] [Abstract][Full Text] [Related]
11. Use of modified functional assays for activated protein C resistance in patients with basally prolonged aPTT.
Montaruli B; Schinco P; Pannocchia A; Giorgianni A; Borchiellini A; Tamponi G; Pileri A
Thromb Haemost; 1997 Sep; 78(3):1042-8. PubMed ID: 9308751
[TBL] [Abstract][Full Text] [Related]
12. The diagnosis of lupus anticoagulants by the activated partial thromboplastin time--the central role of phosphatidyl serine.
Kelsey PR; Stevenson KJ; Poller L
Thromb Haemost; 1984 Oct; 52(2):172-5. PubMed ID: 6441303
[TBL] [Abstract][Full Text] [Related]
13. Lupus anticoagulant: case-based external quality assessment.
van den Besselaar AM; Devreese KM; de Groot PG; Castel A
J Clin Pathol; 2009 Aug; 62(8):731-4. PubMed ID: 19638545
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of sensitivity and specificity of confirmatory assays for lupus anticoagulant (LA) detection].
Imoto K; Yasumuro Y; Taki M; Suzuki Y; Akatu S; Tajima C; Ichikawa Y
Rinsho Byori; 1996 Aug; 44(8):797-801. PubMed ID: 8816068
[TBL] [Abstract][Full Text] [Related]
15. Testing strategies for diagnosing lupus anticoagulant: decision analysis.
Segal JB; Lehmann HP; Petri M; Mueller L; Kickler TS
Am J Hematol; 2002 Jul; 70(3):195-205. PubMed ID: 12111765
[TBL] [Abstract][Full Text] [Related]
16. Factor VIII inhibitors. Laboratory diagnosis of inhibitors.
Sahud MA
Semin Thromb Hemost; 2000; 26(2):195-203. PubMed ID: 10919413
[TBL] [Abstract][Full Text] [Related]
17. Applying a direct aPTT ratio (PlatelinLS/ActinFS) permits to identify rapidly and reliably a bleeding-related factor deficiency or a lupus anticoagulant sequential to an isolated prolongation of aPTT in paediatric pre-operative screening.
Li R; Swaelens C; Vandermijnsbrugge F; Cantinieaux B
Eur J Haematol; 2016 Jun; 96(6):578-85. PubMed ID: 26179977
[TBL] [Abstract][Full Text] [Related]
18. Detection and quantitative evaluation of lupus circulating anticoagulant activity.
Rosner E; Pauzner R; Lusky A; Modan M; Many A
Thromb Haemost; 1987 Apr; 57(2):144-7. PubMed ID: 3110995
[TBL] [Abstract][Full Text] [Related]
19. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification.
Triplett DA; Barna LK; Unger GA
Thromb Haemost; 1993 Nov; 70(5):787-93. PubMed ID: 8128436
[TBL] [Abstract][Full Text] [Related]
20. The Activated Seven Lupus Anticoagulant (ASLA) test has comparable sensitivity to classical assays for screening of lupus anticoagulant.
Marinuzzo M; Adamczuk Y; Varela ML; Pombo G; Forastiero R
Thromb Haemost; 2005 May; 93(5):1007-9. PubMed ID: 15900652
[No Abstract] [Full Text] [Related]
[Next] [New Search]